Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $45.33M | +151.4% |
| 2024 | $-88.27M | +85.2% |
| 2023 | $-595.51M | -15.6% |
| 2022 | $-515.27M | +8.7% |
| 2021 | $-564.23M | -240.1% |
| 2020 | $-165.91M | +22.0% |
| 2019 | $-212.83M | -62.2% |
| 2018 | $-131.24M | -181.7% |
| 2017 | $-46.60M | -79.2% |
| 2016 | $-26.00M | - |